Skip to main content
Fig. 1 | Critical Care

Fig. 1

From: Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship

Fig. 1

Identification of study population. Short-course antibacterial group did not receive empiric antibacterials from RVP+3 to RVP+10, long-course antibacterial group received empiric antibacterials between RVP+3 and RVP+10, and mixed viral–bacterial infection group included patients with both identification of a respiratory virus and a bacterial pathogen. NP nasopharyngeal, R/E rhinovirus/enterovirus, RVP respiratory virus panel, RVP+3 3 days after index RVP, RVP+10 10 days after index RVP

Back to article page

Critical Care

ISSN: 1364-8535